Browsing Tag

antiBTLA

Junshi Biosciences Announces Updated Clinical data from Phase I study of anti-BTLA…

Dustin Moskovitz Dec 11, 2022 0

This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients.…

Health

AnaptysBio Announces Positive ANB032 (anti-BTLA agonist) Top-Line Phase 1 Data and…

Eli Pacheco Apr 28, 2022 0

ANB032, our wholly owned anti-BTLA agonist antibody, demonstrated favorable safety, tolerability and a rapid and sustained pharmacokinetic and pharmacodynamic profile that supports…